{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:24:34Z","timestamp":1787275474097,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05822-8","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:08:15Z","timestamp":1787274495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["7-Deshydroxypyrogallin-4-carboxylic acid dietary phytochemical as a putative FTO inhibitor in breast cancer: an integrated computational and cytotoxicity study"],"prefix":"10.1007","author":[{"given":"Shuaib","family":"Pasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamanth D.","family":"Harishkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revanth Handralu","family":"Chandraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manohar M.","family":"V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devananda","family":"Devegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Kollur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Shivamallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav","family":"Shreevatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Dharmashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"5822_CR1","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.21873\/anticanres.15412","volume":"41","author":"UM Acuna","year":"2021","unstructured":"Acuna UM, Ezzone N, Rakotondraibe LH, Carcache De Blanco EJ (2021) Activity in MCF-7 estrogen-sensitive breast cancer cells of capsicodendrin from Cinnamosma fragrans. Anticancer Res 41:5935\u20135944. https:\/\/doi.org\/10.21873\/anticanres.15412","journal-title":"Anticancer Res"},{"key":"5822_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137400","volume":"1301","author":"Z Akbari","year":"2024","unstructured":"Akbari Z, Stagno C, Iraci N, Efferth T, Omer EA, Piperno A et al (2024) Biological evaluation, DFT, MEP, HOMO-LUMO analysis and ensemble docking studies of Zn(II) complexes of bidentate and tetradentate Schiff base ligands as antileukemia agents. J Mol Struct 1301:137400. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137400","journal-title":"J Mol Struct"},{"key":"5822_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1339891","volume":"12","author":"AA Alzain","year":"2024","unstructured":"Alzain AA, Elbadwi FA, Shoaib TH, Sherif AE, Osman W, Ashour A et al (2024) Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies. Front Chem 12:1339891. https:\/\/doi.org\/10.3389\/fchem.2024.1339891","journal-title":"Front Chem"},{"key":"5822_CR4","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B, Ye F, Yu L, Jia G, Huang X, Zhang X et al (2012) Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc 134:17963\u201317971. https:\/\/doi.org\/10.1021\/ja3064149","journal-title":"J Am Chem Soc"},{"key":"5822_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"5822_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/ml2003058","volume":"3","author":"H Deng","year":"2012","unstructured":"Deng H, Hu H, Ling S, Ferrie AM, Fang Y (2012) Discovery of natural phenols as G protein-coupled receptor-35 (GPR35) agonists. ACS Med Chem Lett 3:165\u2013169. https:\/\/doi.org\/10.1021\/ml2003058","journal-title":"ACS Med Chem Lett"},{"key":"5822_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031106","volume":"28","author":"C Dharmashekar","year":"2023","unstructured":"Dharmashekar C, Shreevatsa B, Jain AS, Harendra B, Pradeep S, Vishwanath PM et al (2023) Evaluating the antimicrobial and anti-hemolytic activity of synthesized pseudopeptide against leptospiral species: in silico and in vitro approach. Molecules 28:1106. https:\/\/doi.org\/10.3390\/molecules28031106","journal-title":"Molecules"},{"key":"5822_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102668","volume":"10","author":"S Ghareghomi","year":"2022","unstructured":"Ghareghomi S, Habibi-Rezaei M, Arese M, Saso L, Moosavi-Movahedi AA (2022) Nrf2 modulation in breast cancer. Biomedicines 10:2668. https:\/\/doi.org\/10.3390\/biomedicines10102668","journal-title":"Biomedicines"},{"key":"5822_CR9","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J et al (2024) Breast cancer statistics 2024. CA Cancer J Clin 74:477\u2013495","journal-title":"CA Cancer J Clin"},{"key":"5822_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40203-026-00600-z","volume":"14","author":"SD Harishkumar","year":"2026","unstructured":"Harishkumar SD, Pasha S, Harendra B, Dharmashekar C, Jain A, Shivamallu C et al (2026) Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach. In Silico Pharmacol 14:117. https:\/\/doi.org\/10.1007\/s40203-026-00600-z","journal-title":"In Silico Pharmacol"},{"key":"5822_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1298786","volume":"14","author":"A Jain","year":"2024","unstructured":"Jain A, Shreevatsa B, Rajendrasozhan S, Dharmashekar C, Suresh KP, Shivamallu C et al (2024) Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials. Front Oncol 14:1298786. https:\/\/doi.org\/10.3389\/fonc.2024.1298786","journal-title":"Front Oncol"},{"key":"5822_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10549-011-1629-5","volume":"132","author":"M Jamshidi","year":"2012","unstructured":"Jamshidi M, Bartkova J, Greco D, Tommiska J, Fagerholm R, Aittom\u00e4ki K et al (2012) NQO1 expression correlates inversely with NF\u03baB activation in human breast cancer. Breast Cancer Res Treat 132:955\u2013968. https:\/\/doi.org\/10.1007\/s10549-011-1629-5","journal-title":"Breast Cancer Res Treat"},{"key":"5822_CR13","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1007\/s00210-024-03625-3","volume":"398","author":"CP Joshi","year":"2025","unstructured":"Joshi CP, Baldi A, Kumar N, Pradhan J (2025) Harnessing network pharmacology in drug discovery: an integrated approach. Naunyn Schmiedebergs Arch Pharmacol 398:4689\u20134703. https:\/\/doi.org\/10.1007\/s00210-024-03625-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5822_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151272","volume":"13","author":"AA Khan","year":"2024","unstructured":"Khan AA, Arutla V, Srivenugopal KS (2024) Human NQO1 as a selective target for anticancer therapeutics and tumor imaging. Cells (Basel) 13:1272. https:\/\/doi.org\/10.3390\/cells13151272","journal-title":"Cells (Basel)"},{"key":"5822_CR15","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E et al (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31:1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"5822_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ani14162434","volume":"14","author":"R Li","year":"2024","unstructured":"Li R, Cao Y, Wu W, Liu H, Xu S (2024) Inhibitor of FTO, Rhein, restrains the differentiation of myoblasts and delays skeletal muscle regeneration. Animals (Basel) 14:2434. https:\/\/doi.org\/10.3390\/ani14162434","journal-title":"Animals (Basel)"},{"key":"5822_CR17","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W et al (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17:4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"key":"5822_CR18","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1158\/0008-5472.CAN-24-0800","volume":"84","author":"M Luo","year":"2024","unstructured":"Luo M, Shen N, Shang L, Fang Z, Xin Y, Ma Y et al (2024) Simultaneous targeting of NQO1 and SOD1 eradicates breast cancer stem cells via mitochondrial futile redox cycling. Cancer Res 84:4264\u20134282. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0800","journal-title":"Cancer Res"},{"key":"5822_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1578094","volume":"16","author":"J Mao","year":"2025","unstructured":"Mao J (2025) The role of genes and network pharmacology in new drug discovery. Front Genet 16:1578094. https:\/\/doi.org\/10.3389\/fgene.2025.1578094","journal-title":"Front Genet"},{"key":"5822_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310737","volume":"24","author":"V Mar\u00edn","year":"2023","unstructured":"Mar\u00edn V, Burgos V, P\u00e9rez R, Maria DA, Pardi P, Paz C (2023) The potential role of epigallocatechin-3-gallate (EGCG) in breast cancer treatment. Int J Mol Sci 24:10737. https:\/\/doi.org\/10.3390\/ijms241310737","journal-title":"Int J Mol Sci"},{"key":"5822_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L et al (2019) RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18:46. https:\/\/doi.org\/10.1186\/s12943-019-1004-4","journal-title":"Mol Cancer"},{"key":"5822_CR22","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1984","volume":"6","author":"EA Orellana","year":"2016","unstructured":"Orellana EA, Kasinski AL (2016) Sulforhodamine B (SRB) assay in cell culture to investigate cell proliferation. Bio Protoc 6:e1984. https:\/\/doi.org\/10.21769\/BioProtoc.1984","journal-title":"Bio Protoc"},{"key":"5822_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7120417","volume":"7","author":"A Phuwajaroanpong","year":"2022","unstructured":"Phuwajaroanpong A, Chaniad P, Plirat W, Phoopha S, Septama AW, Chukaew A, Punsawad C (2022) Antiplasmodial properties of aqueous and ethanolic extracts of ten herbal traditional recipes used in Thailand against Plasmodium falciparum. Trop Med Infect Dis 7:417. https:\/\/doi.org\/10.3390\/tropicalmed7120417","journal-title":"Trop Med Infect Dis"},{"key":"5822_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26226863","volume":"26","author":"B Shreevatsa","year":"2021","unstructured":"Shreevatsa B, Dharmashekara C, Swamy VH, Gowda MV, Achar RR, Kameshwar VH et al (2021) Virtual screening for potential phytobioactives as therapeutic leads to inhibit NQO1 for selective anticancer therapy. Molecules 26:6863. https:\/\/doi.org\/10.3390\/molecules26226863","journal-title":"Molecules"},{"key":"5822_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1427632","volume":"14","author":"B Shreevatsa","year":"2024","unstructured":"Shreevatsa B, Hegde S, Narayan P, Dharmashekar C, Jain A, Shivamallu C et al (2024) Targeting FAK, VEGF, and MTA1 proteins with Terminalia elliptica: a computational approach for anticancer activity. Front Oncol 14:1427632. https:\/\/doi.org\/10.3389\/fonc.2024.1427632","journal-title":"Front Oncol"},{"key":"5822_CR26","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1073\/pnas.0501828102","volume":"102","author":"P Tsvetkov","year":"2005","unstructured":"Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J (2005) Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A 102:5535\u20135540. https:\/\/doi.org\/10.1073\/pnas.0501828102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5822_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004914","volume":"4","author":"D Wu","year":"2009","unstructured":"Wu D, Pang Y, Ke Y, Yu J, He Z, Tautz L, Mustelin T, Ding S, Huang Z, Feng GS (2009) A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by Shp2 tyrosine phosphatase. PLoS ONE 4:e4914. https:\/\/doi.org\/10.1371\/journal.pone.0004914","journal-title":"PLoS ONE"},{"key":"5822_CR28","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41366-018-0082-5","volume":"42","author":"R Wu","year":"2018","unstructured":"Wu R, Yao Y, Jiang Q, Cai M, Liu Q, Wang Y et al (2018) Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner. Int J Obes 42:1378\u20131379. https:\/\/doi.org\/10.1038\/s41366-018-0082-5","journal-title":"Int J Obes"},{"key":"5822_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-33-14","volume":"33","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S et al (2014) Clinical implications of high NQO1 expression in breast cancers. J Exp Clin Cancer Res 33:14. https:\/\/doi.org\/10.1186\/1756-9966-33-14","journal-title":"J Exp Clin Cancer Res"},{"key":"5822_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10238-025-01872-z","volume":"25","author":"J Zhang","year":"2025","unstructured":"Zhang J, Meng X, Zhao B, Wang H, Hu Q, Wang S et al (2025) FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE. Clin Exp Med 25:320. https:\/\/doi.org\/10.1007\/s10238-025-01872-z","journal-title":"Clin Exp Med"},{"key":"5822_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.983564","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou M, Dong M, Yang X, Gong J, Liao X, Zhang Q, Liu Z (2022) The emerging roles and mechanism of m6A in breast cancer progression. Front Genet 13:983564. https:\/\/doi.org\/10.3389\/fgene.2022.983564","journal-title":"Front Genet"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05822-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:08:16Z","timestamp":1787274496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05822-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":31,"alternative-id":["5822"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05822-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}